Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial

Autor:	Zeki Gokhan Surmeli, Isa Dede, Mert Basaran, Metin Kanitez, Muhammet Ali Kaplan, Nilufer Avci, Meltem Ekenel, Vedat Bayoglu, Tulay Akman, Mukremin Uysal, Umut Varol, Muharrem Kocar, Ozan Yazıcı, Arife Ulas, Deniz Tural, Ibrahim Yildiz
Rok vydání:	2014
Předmět:	Oncology Cancer Research medicine.medical_specialty Sunitinib business.industry Turkish urologic and male genital diseases medicine.disease language.human_language Renal cell carcinoma Internal medicine medicine language In patient business Clear cell medicine.drug
Zdroj:	Journal of Clinical Oncology. 32:e15602-e15602
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2014.32.15_suppl.e15602
Popis:	e15602 Background: Most of the randomizedstudies that have evaluated the clinical outcome of anti-VEGF treatment in metastatic renal cell carcinoma (RCC) were focused mostly on the clear cell histo...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554fd4727772a4131bdfb764bba8268b https://doi.org/10.1200/jco.2014.32.15_suppl.e15602 Zobrazit plný text záznamu